• Eduardo R Argaiz, Linda Morales-Juárez, Christian Razo, Liane Ong, Quinn Rafferty, Rodolfo Rincón-Pedrero, and Gerardo Gamba.
• Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.
• Gac Med Mex. 2023 Jan 1; 159 (6): 487493487-493.

BackgroundChronic kidney disease (CKD) represents a substantial global burden of disease due to a lack of universal tests and misinterpretation of biomarkers.ObjectiveTo analyze CKD epidemiology in Mexico and guide public policies.Material And MethodsData from the Global Burden of Disease (GBD) 2021 study were used to describe CKD prevalence and mortality in Mexico for the 1990-2021 period, stratifying by gender and age groups.ResultsThe prevalence of CKD in Mexico in 2021 was 9,184.9 per 100,000 population. Diabetes was the most common cause of CKD, and CKD-related mortality was high, with an increase in 2019 and 2021, possibly as a consequence of the COVID-19 pandemic.ConclusionsCKD in Mexico entails a high burden of mortality and years of life lost, but it barely contributes to disability. It is essential to improve CKD early detection, access to treatments and coding of the causes of the disease. Moreover, investigating the causes of CKD of unknown etiology, including genetic factors, is crucial in order for specific treatments to be developed in the future.Copyright: © 2023 Permanyer.

15 keywords...

hide…